These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7446539

  • 1. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory.
    Newton DW, Kluza RB.
    Am J Hosp Pharm; 1980 Dec; 37(12):1647-51. PubMed ID: 7446539
    [Abstract] [Full Text] [Related]

  • 2. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ, Ueda CT, Newton DW.
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Compatibility and pH variability of four injectable phenytoin sodium products.
    Markowsky SJ, Kohls PR, Ehresman D, Leppik I.
    Am J Hosp Pharm; 1991 Mar; 48(3):510-4. PubMed ID: 2028998
    [Abstract] [Full Text] [Related]

  • 6. A 5% glucose infusion fluid provokes significant precipitation of phenytoin sodium injection via interruption of the cosolvent effect of propylene glycol.
    Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K.
    Chem Pharm Bull (Tokyo); 2012 Mar; 60(1):86-93. PubMed ID: 22223379
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solubility and ionization characteristics of phenytoin.
    Schwartz PA, Rhodes CT, Cooper JW.
    J Pharm Sci; 1977 Jul; 66(7):994-7. PubMed ID: 18594
    [Abstract] [Full Text] [Related]

  • 10. Lorazepam solubility in and sorption from intravenous admixture solutions.
    Newton DW, Narducci WA, Leet WA, Ueda CT.
    Am J Hosp Pharm; 1983 Mar; 40(3):424-7. PubMed ID: 6133447
    [Abstract] [Full Text] [Related]

  • 11. Estimation of drug precipitation upon dilution of pH-controlled formulations.
    Narazaki R, Sanghvi R, Yalkowsky SH.
    Mol Pharm; 2007 Mar; 4(4):550-5. PubMed ID: 17530775
    [Abstract] [Full Text] [Related]

  • 12. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
    Gardella LA, Zaroslinski JF, Possley LH.
    Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
    [Abstract] [Full Text] [Related]

  • 13. Crystallization of three phenytoin preparations in intravenous solutions.
    Giacona N, Bauman JL, Siepler JK.
    Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ, Fishman DA, Kochis TR.
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [Abstract] [Full Text] [Related]

  • 19. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations.
    Narazaki R, Sanghvi R, Yalkowsky SH.
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1203-6. PubMed ID: 17666845
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.